Atropine Shows Effect on Superficial Retinal Perfusion
via HealthDayTUESDAY, May 12, 2026 -- For healthy adults, a single instillation of 0.01 to 0.1 percent atropine does not change axial length or retinal or choroidal thickness over 24 hours, but may transiently affect superficial retinal perfusion, according to a study recently published in Eye & Vision.
Barsha Lal, Ph.D., and Lisa A. Ostrin, O.D., Ph.D., from the University of Houston College of Optometry, examined the short-term effects of a range of low atropine concentrations on axial length, retinal and choroidal thickness, and microvasculature in a double-masked, randomized study involving 20 healthy adults (mean age, 25.5 ± 3.4 years). Participants received a single instillation of placebo or 0.01, 0.025, 0.05, or 0.1 percent atropine in the right eye in five sessions.
The researchers observed no significant changes in retinal or choroidal thickness or axial length for any concentration or time point. A significant decrease was seen in the superficial vascular plexus perfusion density in the 1.0- to 2.5-mm annulus with time after atropine instillation, but not with concentration; a significant decrease from baseline was seen at one hour versus 24 hours in a post-hoc analysis.
"By linking objective ocular responses with subjective visual experience, this work advances our understanding of how atropine works and supports more precise, evidence-based, and individualized approaches to myopia management," Ostrin said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-13 02:44
Read more
- Social Media Captures GLP-1 Receptor Agonist Side Effects Not Seen in Clinical Trials
- Multiple Myeloma Linked to Higher Risk for Hematologic Second Cancers
- Why Doctors Are Quitting At An Earlier Age
- Cantaloupes Recalled in Four States Due to Salmonella Risk
- Metabolic Syndrome Tied To Cancer Risk
- Ketogenic Diet Cuts Proportion of Proinsulin Secreted in Type 2 Diabetes
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions